 | Staurosporine | IC50 | 1.3 [1], 8.63 [2], 12.4 [3], 53.0 [4] |
 | CID 44462758 | IC50 | 60.0 [1], 68.0 [2], 1805.0 [3] |
 | Doramapimod | IC50 | 20000.0 [1], 30000.0 [2] |
 | 2-(2-Aminoethylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide | IC50 | 5011.87 [1], 5200.0 [2] |
 | 5-[[(1S,2R)-2-Aminocyclohexyl]amino]-7-(3,5-dimethoxyanilino)-[1,2,4]triazolo[4,3-c]pyrimidine-8-carboxamide | IC50 | 120.0 [1] |
 | 5-[[(1S,2R)-2-Aminocyclohexyl]amino]-7-(3,5-dimethoxyanilino)-[1,2,4]triazolo[1,5-c]pyrimidine-8-carboxamide | IC50 | 330.0 [1] |
 | {4-[6-((S)-3-Methyl-piperazin-1-yl)-pyridin-3-yl]-pyrimidin-2-yl}-(3,4,5-trimethoxy-phenyl)-amine | IC50 | 11.0 [1] |
 | 5-Amino-7-(3,5-dimethoxyanilino)imidazo[1,2-c]pyrimidine-8-carboxamide | IC50 | 10000.0 [1] |
 | 7-(3,5-Dimethoxyanilino)-5-(2-hydroxyethylamino)imidazo[1,2-c]pyrimidine-8-carboxamide | IC50 | 1900.0 [1] |
 | 5-(2-Aminoethylamino)-7-(3,5-dimethoxyanilino)imidazo[1,2-c]pyrimidine-8-carboxamide | IC50 | 3500.0 [1] |
 | 1,2,4-Oxadiazole Analogue 5d | IC50 | 6000.0 [1], 7000.0 [2] |
 | 1,2,4-Oxadiazole Analogue 12b | IC50 | 4000.0 [1] |
 | 1,2,4-Oxadiazole Analogue 12d | IC50 | 4000.0 [1] |
 | 1,2,4-Oxadiazole Analogue 5f | IC50 | 6000.0 [1], 7000.0 [2] |
 | 5-{[(1R,2S)-2-Aminocyclohexyl]amino}-3-[(4,6-dimethylpyridin-2-yl)amino]pyridine-2-carboxamide | IC50 | 5.3 [1] |
 | 3-{[(1r,2s)-2-Aminocyclohexyl]amino}-5-(1h-Indol-7-Ylamino)-1,2,4-Triazine-6-Carboxamide | IC50 | 251.0 [1], 2526.0 [2] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-oxobutanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-phosphonooxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]butanedioic acid | IC50 | 30.0 [1] |
 | Alvocidib | IC50 | 50000.0 [1] |
 | 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 100000000.0 [1] |
 | Semaxanib | IC50 | 20700.0 [1] |
 | 6-Dimethylaminopurine | Ki | 10000.0 [1] |
 | Ceritinib | IC50 | 9700.0 [1] |
 | Tyrphostin A23 | Ki | 10000.0 [1] |
 | Sotrastaurin | IC50 | 10000.0 [1] |
 | Met Kinase Inhibitor | Ki | 10000.0 [1] |
 | Orantinib | IC50 | 28400.0 [1] |
 | Nvp-aew541 | IC50 | 10000.0 [1] |
 | Sns-032 | IC50 | 40000.0 [1] |
 | Nvp-tae 684 | IC50 | 1598.0 [1] |
 | Danusertib | IC50 | 10000.0 [1] |
 | Neflamapimod | IC50 | 5000.0 [1] |
 | Entrectinib | IC50 | 10000.0 [1] |
 | Azd-1152hqpa | Ki | 8200.0 [1] |
 | 2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | IC50 | 10000.0 [1] |
 | Tamatinib | IC50 | 42.0 [1] |
 | Milciclib | IC50 | 10000.0 [1] |
 | O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine | Ki | 10000.0 [1] |
 | 4-Amino-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl-Cyclopentane | IC50 | 50000.0 [1] |
 | 3-(1H-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridine | IC50 | 5050.0 [1] |
 | 7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine | IC50 | 20000.0 [1] |
 | A-770041 | IC50 | 25000.0 [1] |
 | (4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 10000.0 [1] |
 | Cdk2 Inhibitor II | Ki | 10000.0 [1] |
 | Syk Inhibitor II | IC50 | 11200.0 [1] |
 | Bms-509744 | IC50 | 50000.0 [1] |
 | 4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide | IC50 | 25000.0 [1] |
 | Nms-P937 (nms1286937) | IC50 | 10000.0 [1] |
 | CID 11634725 | Ki | 4000.0 [1] |
 | Pyrimidone, 22 | IC50 | 5400.0 [1] |
 | 7-Butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine | Ki | 2630.27 [1] |
 | 2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-one | IC50 | 8300.0 [1] |
 | Mivavotinib | IC50 | 75.0 [1] |
 | CID 59604787 | IC50 | 10000.0 [1] |
 | 5-[2,4-Dihydroxy-6-(4-Nitrophenoxy)phenyl]-N-(1-Methylpiperidin-4-Yl)-1,2-Oxazole-3-Carboxamide | IC50 | 10.0 [1] |
 | (4S)-4-[[(2S)-2-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | IC50 | 530000.0 [1] |
 | 2-{[(3r,4r)-3-Aminotetrahydro-2h-Pyran-4-Yl]amino}-4-[(4-Methylphenyl)amino]pyrimidine-5-Carboxamide | IC50 | 19952.62 [1] |
 | N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)urea | IC50 | 10000.0 [1] |
 | CID 44814409 | IC50 | 10000.0 [1] |
 | N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamide | IC50 | 10000.0 [1] |
 | 5-(2-Aminopyrimidin-4-yl)-2-phenyl-1H-pyrrole-3-carboxamide | IC50 | 10000.0 [1] |
 | 2-[1-(4,4-Difluorocyclohexyl)-piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide | IC50 | 10000.0 [1] |
 | (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 1000.0 [1] |
 | Unii-8FX9DP2Y1W | IC50 | 1000.0 [1] |
 | 9H-Imidazo(4,5-H)isoquinolin-9-one, 2-((2,6-dichlorophenyl)amino)-1,8-dihydro-6,7-dimethyl- | IC50 | 80000.0 [1] |
 | Lck Inhibitor | IC50 | 1500.0 [1] |
 | 2-(2-Aminoethylamino)-4-(p-tolylamino)pyrimidine-5-carboxamide | IC50 | 6500.0 [1] |
 | N'-(5-Chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine | IC50 | 30000.0 [1] |
 | Unii-09RR39UU4V | IC50 | 50000.0 [1] |
 | (E)-3-[4-[[[8-Carbamoyl-7-(3,5-dimethoxyanilino)imidazo[1,2-c]pyrimidin-5-yl]amino]methyl]phenyl]prop-2-enoic acid | IC50 | 47.0 [1] |
 | 5-(2-Aminoethylamino)-7-(3,5-dimethoxyphenylamino)-1,2,4-triazolo[4,3-c]pyrimidine-8-carboxamide | IC50 | 8300.0 [1] |
 | 5-[[(1R,2S)-2-Aminocyclohexyl]amino]-7-(3,5-dimethoxyanilino)-2-phenylimidazo[1,2-c]pyrimidine-8-carboxamide | IC50 | 600.0 [1] |
 | 3-[[4-[2,2-Dimethylpropyl(methyl)amino]-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazin-2-yl]amino]-N-methoxy-4-methylbenzamide | IC50 | 50000.0 [1] |
 | CID 11675054 | IC50 | 10000.0 [1] |
 | (2,6-Dimethylphenyl) N-[2-[3,5-dimethoxy-4-[3-(4-methylpiperazin-1-yl)propoxy]anilino]pyrimidin-4-yl]-N-(2,4-dimethoxyphenyl)carbamate | IC50 | 370.0 [1] |
 | 3-[(4-Morpholin-4-ylbenzoyl)amino]-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]-1H-thieno[3,2-c]pyrazole-5-carboxamide | IC50 | 10000.0 [1] |
 | 3-[1H-Benzimidazol-2-yl(phenyl)methylene]-1,3-dihydro-2H-indol-2-one | IC50 | 26000.0 [1] |
 | 7-{[(1r,2s)-2-Aminocyclohexyl]amino}-5-(1h-Indol-7-Ylamino)pyrido[4,3-D]pyrimidin-4(3h)-One | IC50 | 133.0 [1] |
 | 8-[2-(Dimethylamino)ethoxy]-2-(4-phenoxyphenyl)-6,11-dihydro-5H-pyrazolo[5,1-b][1,3]benzodiazepine-1-carboxamide | IC50 | 1000.0 [1] |
 | (3E)-3-[(4-Hydroxyphenyl)methylidene]-1-[(3E)-3-[(4-hydroxyphenyl)methylidene]-2-oxo-3a,4-dihydrocyclopenta[b]indol-1-yl]cyclopenta[b]indol-2-one | Ki | 1548.82 [1] |
 | 7-[[(1R,2S)-2-Aminocyclohexyl]amino]-5-[3-(triazol-2-yl)anilino]-3H-pyrido[4,3-d]pyrimidin-4-one | IC50 | 74.0 [1] |
 | (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
 | 4-Methyl-3-[2-(methylamino)quinazolin-6-yl]-N-[2-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]benzamide | IC50 | 25000.0 [1] |
 | N-[2-[3-(Dimethylamino)propyl-methylamino]-5-(trifluoromethyl)phenyl]-2-fluoro-5-[3-[4-(methylamino)-1,3,5-triazin-2-yl]pyridin-2-yl]oxybenzamide | IC50 | 25000.0 [1] |
 | 2-(2-Aminoethylamino)-4-(phenylamino)pyrimidine-5-carboxamide | IC50 | 13200.0 [1] |
 | 2-[2-(3,5-Dimethylanilino)pyrimidin-4-yl]-N-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,3-thiazole-5-carboxamide | Ki | 240.0 [1] |
 | 3-[3-[[4-(1,3-Thiazol-2-yl)pyrimidin-2-yl]amino]-5-(trifluoromethyl)phenoxy]propan-1-ol | Ki | 677.0 [1] |
 | 2-(2-Aminoethylamino)-4-(3-cyanophenylamino)pyrimidine-5-carboxamide | IC50 | 8400.0 [1] |
 | 7-(3,5-Dimethoxyanilino)-5-[(2-methylcyclohexyl)amino]imidazo[1,2-c]pyrimidine-8-carboxamide | IC50 | 3300.0 [1] |
 | 2-(4-Methyl-2-(2-(3-methyl-5-(trifluoromethyl)phenylamino)pyrimidin-4-yl)thiazol-5-yl)ethanol | Ki | 3500.0 [1] |
 | 2-(2-(2-(3,5-Dimethylphenylamino)pyrimidin-4-yl)-4-methylthiazol-5-yl)ethanol | Ki | 560.0 [1] |
 | N-(3,5-Dimethylphenyl)-4-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine | Ki | 1030.0 [1] |
 | N-[3-Methyl-5-(trifluoromethyl)phenyl]-4-(1,3-thiazol-2-yl)pyrimidin-2-amine | Ki | 891.0 [1] |
 | 2-[2-(3,5-Dimethylanilino)pyrimidin-4-yl]-N-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,3-thiazole-5-carboxamide | Ki | 1500.0 [1] |
 | 4-(4-Fluorophenyl)-N-[4-[3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl]oxyphenyl]phthalazin-1-amine | IC50 | 25000.0 [1] |
 | 3-Substituted indolin-2-one 11a | IC50 | 25000.0 [1] |
 | 1,2,4-Oxadiazole Analogue 4i | IC50 | 55000.0 [1] |
 | 1,2,4-Oxadiazole Analogue 4k | IC50 | 500000.0 [1] |
 | 1,2,4-Oxadiazole Analogue 4a | IC50 | 500000.0 [1] |
 | 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
 | 7,8-Dichloro-9-methyl-1-oxospiro[2,4-dihydropyrido[3,4-b]indole-3,4'-piperidine]-4-carbonitrile | IC50 | 10000.0 [1] |
Calculator
